{
  "denotations": [
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 0,
        "end": 4
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 43,
        "end": 52
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 94,
        "end": 98
      }
    },
    {
      "id": "T4",
      "obj": "Disease",
      "span": {
        "begin": 94,
        "end": 124
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 27,
        "end": 38
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 0,
        "end": 26
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "21676217_3",
  "text": "HER2 -related target drugs trastuzumab and lapatinib have been the foundation of treatment of HER2 -- positive breast cancer ."
}
